RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS banner

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E

Watchlist Manager
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS Logo
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
Watchlist
Price: 3.51 TRY -4.1% Market Closed
Market Cap: ₺1.8B

Cash Flow Statement

Cash Flow Statement
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS

Rotate your device to view
Cash Flow Statement
Currency: TRY
Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025 Dec-2025
Operating Cash Flow
Net Income
78
96
107
91
127
140
154
272
288
301
249
(71)
(0)
(185)
(223)
52
141
430
424
881
Depreciation & Amortization
2
3
3
3
4
5
5
6
23
8
7
18
15
26
20
26
21
17
29
32
Other Non-Cash Items
5
(10)
(18)
(18)
(115)
(193)
(234)
(301)
(201)
(206)
(216)
211
126
283
33
(256)
(324)
(576)
(264)
(785)
Cash Taxes Paid
8
20
19
15
12
14
17
14
5
3
3
4
4
0
3
0
0
0
0
0
Cash Interest Paid
2
4
6
6
5
3
4
13
28
16
14
29
26
39
52
102
102
101
89
71
Change in Working Capital
(76)
(113)
(50)
(28)
52
50
(19)
(23)
(191)
(47)
12
(83)
(137)
(110)
(116)
32
52
31
18
24
Cash from Operating Activities
9
N/A
(25)
N/A
43
N/A
47
+10%
69
+45%
2
-98%
(94)
N/A
(45)
+52%
(233)
-413%
56
N/A
53
-4%
43
-19%
4
-90%
14
+222%
(286)
N/A
(130)
+55%
(109)
+16%
(98)
+10%
208
N/A
152
-27%
Investing Cash Flow
Capital Expenditures
(17)
(21)
(26)
(19)
(22)
(22)
(14)
(21)
(37)
(22)
(27)
(48)
(21)
(22)
(16)
(126)
(98)
(100)
(98)
(33)
Other Items
1
1
3
3
17
26
13
13
(91)
40
28
89
(22)
(18)
182
93
180
286
111
114
Cash from Investing Activities
(16)
N/A
(19)
-18%
(24)
-22%
(16)
+33%
(5)
+71%
4
N/A
(1)
N/A
(8)
-1 197%
(128)
-1 549%
18
N/A
1
-97%
41
+6 745%
(44)
N/A
(40)
+8%
166
N/A
(33)
N/A
82
N/A
186
+128%
13
-93%
81
+543%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
48
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Issuance of Debt
13
30
26
24
32
16
23
30
(36)
26
(17)
(99)
(119)
(124)
53
201
102
(13)
(161)
(176)
Other
(1)
(4)
(6)
(6)
(4)
(3)
(5)
(14)
23
(14)
(11)
(12)
(10)
(22)
(40)
(91)
(92)
(90)
(72)
(60)
Cash from Financing Activities
12
N/A
26
+116%
20
-24%
18
-9%
76
+322%
61
-20%
66
+9%
64
-4%
(14)
N/A
12
N/A
(28)
N/A
(111)
-299%
(130)
-17%
(146)
-13%
13
N/A
110
+754%
10
-91%
(103)
N/A
(233)
-126%
(237)
-2%
Change in Cash
Net Change in Cash
5
N/A
(18)
N/A
39
N/A
50
+26%
140
+183%
67
-52%
(28)
N/A
10
N/A
(375)
N/A
86
N/A
26
-70%
(27)
N/A
(169)
-516%
(172)
-2%
(108)
+37%
(53)
+51%
(17)
+67%
(16)
+10%
(12)
+21%
(4)
+69%
Free Cash Flow
Free Cash Flow
(7)
N/A
(45)
-512%
17
N/A
28
+67%
47
+67%
(20)
N/A
(107)
-434%
(66)
+39%
(270)
-308%
34
N/A
26
-23%
(5)
N/A
(17)
-215%
(8)
+52%
(303)
-3 597%
(256)
+15%
(208)
+19%
(199)
+4%
110
N/A
119
+8%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett